Skip to main content
Premium Trial:

Request an Annual Quote

NGeneBio, Genoks Ink Middle East, Western Asia Dx Marketing Deal

NEW YORK — NGeneBio said on Tuesday that it has signed a memorandum of understanding to offer its next-generation sequencing-based diagnostics in the Middle East and western Asia in partnership with Turkish genomics healthcare company Genoks.

Under the terms of the arrangement, South Korea-based NGeneBio will provide its sequencing panels, data analysis software, and nucleic acid extraction systems to Genoks, which will use the technologies to perform diagnostic testing on samples collected from patients in Turkey, Iran, Azerbaijan, and Cyprus.

Financial and other terms of the deal were not disclosed.

NGeneBio, which primarily offers a range of tests for cancer, received CE marking for a tuberculosis assay.

The Scan

Monkeypox Meeting

As the World Health Organization gets ready to hold another monkeypox meeting, the US distributes vaccines and increases its testing capacity.

CRISPR's Softer Side

A homologous chromosome-templated repair approach to gene editing relies on versions of the Cas9 enzyme that cut a single DNA strand.

Pickled? No Problem

Researchers come up with an approach for extracting DNA from archived museum specimens. 

Nature Papers on Long Reads for Bacterial Genomes, Zebrafish Atlas, Hypothalamic Aging in Mammals

In Nature this week: near-finished microbial genomes without polishing, zebrafish functional annotation program, and more.